BREAST TUMOR
Clinical trials for BREAST TUMOR explained in plain language.
Never miss a new study
Get alerted when new BREAST TUMOR trials appear
Sign up with your email to follow new studies for BREAST TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted drug shows promise for rare genetic cancers, but study halted early
Disease control TerminatedThis study tested the drug niraparib in 22 adults with advanced solid tumors (like breast, lung, or pancreatic cancer) that have a specific PALB2 gene mutation. The goal was to see if the drug could shrink tumors or slow cancer growth. The study was stopped early, so results are …
Matched conditions: BREAST TUMOR
Phase: PHASE2 • Sponsor: Tempus AI • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Experimental cancer drug trial halted early
Disease control TerminatedThis study tested a new drug called NUV-868, alone or combined with other cancer drugs (olaparib or enzalutamide), in people with advanced solid tumors like ovarian, pancreatic, prostate, or breast cancer. The main goals were to check safety and find the right dose. The study was…
Matched conditions: BREAST TUMOR
Phase: PHASE1 • Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated May 04, 2026 16:31 UTC